Experimental studies have shown that CCL5 contributes to demyelination, meanwhile immune neutralizing antibodies against CCL5 inhibit the migration of inflammatory cells and CNS inflammatory infiltration, attenuating myelin loss in MS model animals (Cui, Chu & Chen, 2020). The gene discussed is CCL5; the disease is myeloid sarcoma.